Health In Tech Statistics
Total Valuation
Health In Tech has a market cap or net worth of $88.00 million. The enterprise value is $80.47 million.
Important Dates
The last earnings date was Wednesday, March 25, 2026, after market close.
| Earnings Date | Mar 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health In Tech has 63.31 million shares outstanding. The number of shares has increased by 7.60% in one year.
| Current Share Class | 51.61M |
| Shares Outstanding | 63.31M |
| Shares Change (YoY) | +7.60% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 71.79% |
| Owned by Institutions (%) | 3.40% |
| Float | 12.26M |
Valuation Ratios
The trailing PE ratio is 69.50 and the forward PE ratio is 411.40.
| PE Ratio | 69.50 |
| Forward PE | 411.40 |
| PS Ratio | 2.64 |
| Forward PS | 2.02 |
| PB Ratio | 3.49 |
| P/TBV Ratio | 8.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 28.08 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 62.92 |
| EV / Sales | 2.41 |
| EV / EBITDA | 33.13 |
| EV / EBIT | 52.65 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.13 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.45% and return on invested capital (ROIC) is 12.37%.
| Return on Equity (ROE) | 8.45% |
| Return on Assets (ROA) | 4.92% |
| Return on Invested Capital (ROIC) | 12.37% |
| Return on Capital Employed (ROCE) | 8.52% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $416,594 |
| Profits Per Employee | $15,986 |
| Employee Count | 80 |
| Asset Turnover | 1.72 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health In Tech has paid $395,330 in taxes.
| Income Tax | 395,330 |
| Effective Tax Rate | 23.61% |
Stock Price Statistics
The stock price has increased by +79.36% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +79.36% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 40.62 |
| Average Volume (20 Days) | 578,758 |
Short Selling Information
The latest short interest is 453,623, so 0.72% of the outstanding shares have been sold short.
| Short Interest | 453,623 |
| Short Previous Month | 184,486 |
| Short % of Shares Out | 0.72% |
| Short % of Float | 3.70% |
| Short Ratio (days to cover) | 2.86 |
Income Statement
In the last 12 months, Health In Tech had revenue of $33.33 million and earned $1.28 million in profits. Earnings per share was $0.02.
| Revenue | 33.33M |
| Gross Profit | 20.94M |
| Operating Income | 1.53M |
| Pretax Income | 1.67M |
| Net Income | 1.28M |
| EBITDA | 2.43M |
| EBIT | 1.53M |
| Earnings Per Share (EPS) | $0.02 |
Full Income StatementBalance Sheet
The company has $7.67 million in cash and $139,812 in debt, with a net cash position of $7.53 million or $0.12 per share.
| Cash & Cash Equivalents | 7.67M |
| Total Debt | 139,812 |
| Net Cash | 7.53M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 17.11M |
| Book Value Per Share | 0.40 |
| Working Capital | 11.00M |
Full Balance SheetCash Flow
| Operating Cash Flow | 3.13M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 900,577 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 62.82%, with operating and profit margins of 4.59% and 3.84%.
| Gross Margin | 62.82% |
| Operating Margin | 4.59% |
| Pretax Margin | 5.02% |
| Profit Margin | 3.84% |
| EBITDA Margin | 7.29% |
| EBIT Margin | 4.59% |
| FCF Margin | n/a |
Dividends & Yields
Health In Tech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.60% |
| Shareholder Yield | -7.60% |
| Earnings Yield | 1.45% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Health In Tech is $2.50, which is 79.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.50 |
| Price Target Difference | 79.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
